{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:21:47Z","timestamp":1783016507913,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T00:00:00Z","timestamp":1517270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00415-018-8766-2","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T05:50:08Z","timestamp":1517291408000},"page":"1259-1268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Closure of patent foramen ovale for cryptogenic stroke patients: an updated systematic review and meta-analysis of randomized trials"],"prefix":"10.1007","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2053-3421","authenticated-orcid":false,"given":"Xuan","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ou-Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-fei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-lan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,30]]},"reference":[{"issue":"4","key":"8766_CR1","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despr\u00e9s JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB (2015) Heart disease and stroke statistics\u20142015 update a report from the American Heart Association. Circulation 131(4):e29\u2013e322. \n                    https:\/\/doi.org\/10.1161\/CIR.0000000000000152","journal-title":"Circulation"},{"issue":"6","key":"8766_CR2","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1161\/STROKEAHA.107.502807","volume":"39","author":"D Zhan","year":"2008","unstructured":"Zhan D, Liu J, Wang W, Zeng Z, Cheng J, Liu J, Sun J, Wu Z (2008) Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Bejing Project. Stroke 39(6):1668\u20131674. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.107.502807","journal-title":"Stroke"},{"key":"8766_CR3","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1212\/WNL.0000000000002961","volume":"87","author":"SR Messe","year":"2016","unstructured":"Messe SR, Gronseth G, Kent DM, Kizer JR, Homma S, Homma S, Rosterman L, Kasner SE (2016) Practice advisory: recurrent stroke with patent foramen ovale (update of practice parameter): report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 87:815\u2013821. \n                    https:\/\/doi.org\/10.1212\/wnl.0000000000002961","journal-title":"Neurology"},{"issue":"10","key":"8766_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1056\/NEJM199709043371005","volume":"337","author":"TN Srivastava","year":"1997","unstructured":"Srivastava TN, Payment MF (1997) Images in clinical medicine. Paradoxical embolism\u2014thrombus in transit through a patent foramen ovale. N Engl J Med 337(10):681. \n                    https:\/\/doi.org\/10.1056\/NEJM199709043371005","journal-title":"N Engl J Med"},{"issue":"5","key":"8766_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1159\/000210432","volume":"27","author":"P Amarenco","year":"2009","unstructured":"Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG (2009) Classification of stroke subtypes. Cerebrovasc Dis 27(5):493\u2013501","journal-title":"Cerebrovasc Dis"},{"key":"8766_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.7326\/0003-4819-139-9-200311040-00010","volume":"139","author":"P Khairy","year":"2003","unstructured":"Khairy P, O\u2019Donnell CP, Landzberg MJ (2003) Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 139:753\u2013760. \n                    https:\/\/doi.org\/10.7326\/0003-4819-139-9-200311040-00010","journal-title":"Ann Intern Med"},{"key":"8766_CR7","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1212\/WNL.55.8.1172","volume":"55","author":"JR Overell","year":"2000","unstructured":"Overell JR, Bone I, Lees KR (2000) Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55:1172\u20131179. \n                    https:\/\/doi.org\/10.1212\/wnl.55.8.1172","journal-title":"Neurology"},{"issue":"9","key":"8766_CR8","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.jacc.2005.08.038","volume":"46","author":"H Hara","year":"2005","unstructured":"Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, Gray W, Nakamura M, Mooney M, Poulose A, Schwartz RS (2005) Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol 46(9):1768\u20131776. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2005.08.038","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"8766_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4065\/79.1.15","volume":"79","author":"AH Jr","year":"2004","unstructured":"Jr AH (2004) Patent foramen ovale: paradoxical embolism and paradoxical data. Mayo Clin Proc 79(1):15\u201320. \n                    https:\/\/doi.org\/10.4065\/79.1.15","journal-title":"Mayo Clin Proc"},{"key":"8766_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/STROKEAHA.108.527507","volume":"40","author":"J Rodes-Cabau","year":"2009","unstructured":"Rodes-Cabau J, Noal M, Marrero A, Rivest D, Mackey A, Houde C, B\u00e9dard E, Larose E, Verreault S, Peticlerc M, Pibarot P, Bogaty P, Bertrand OF (2009) Atherosclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale. Stroke 40:419\u2013425. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.108.527507","journal-title":"Stroke"},{"key":"8766_CR11","first-page":"135","volume":"110","author":"J Finsterer","year":"2010","unstructured":"Finsterer J (2010) Management of cryptogenic stroke. Acta Neurol Belg 110:135\u2013147","journal-title":"Acta Neurol Belg"},{"issue":"9","key":"8766_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.7326\/0003-4819-139-9-200311040-00010","volume":"139","author":"P Khairy","year":"2003","unstructured":"Khairy P, O\u2019Donnell CP, Landzberg MJ (2003) Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 139(9):753\u2013760. \n                    https:\/\/doi.org\/10.7326\/0003-4819-139-9-200311040-00010","journal-title":"Ann Intern Med"},{"key":"8766_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/eurheartj\/ehu292","volume":"36","author":"S Stortecky","year":"2015","unstructured":"Stortecky S, da Costa BR, Mattle HP, Carroll J, Hornung M, Sievert H, Trelle S, Windecker S, Meier B, J\u00fcni P (2015) Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Eur Heart J 36:120\u2013128. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehu292","journal-title":"Eur Heart J"},{"key":"8766_CR14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366:991\u2013999. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1009639","journal-title":"N Engl J Med"},{"key":"8766_CR15","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"JD Carroll","year":"2013","unstructured":"Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell Tirschwell DL (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 368:1092\u20131100. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1301440","journal-title":"N Engl J Med"},{"key":"8766_CR16","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"B Meier","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, J\u00fcni P (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 368:1083\u20131091. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1211716","journal-title":"N Engl J Med"},{"key":"8766_CR17","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"JL Saver","year":"2017","unstructured":"Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 377:1022\u20131032. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1610057","journal-title":"N Engl J Med"},{"key":"8766_CR18","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L S\u00f8ndergaard","year":"2017","unstructured":"S\u00f8ndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sj\u00f6strand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 377:1033\u20131042. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1707404","journal-title":"N Engl J Med"},{"key":"8766_CR19","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"JL Mas","year":"2017","unstructured":"Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, B\u00e9jot Y, Vuillier F, Detante O, Guidoux C, Canaple S, Vaduva C, Dequatre-Ponchelle N, Sibon I, Garnier P, Ferrier A, Timsit S, Robinet-Borgomano E, Sablot D, Lacour JC, Zuber M, Favrole P, Pinel JF, Apoil M, Reiner P, Lefebvre C, Gu\u00e9rin P, Piot C, Rossi R, Dubois-Rand\u00e9 JL, Eicher JC, Meneveau N, Lusson JR, Bertrand B, Schleich JM, Godart F, Thambo JB, Leborgne L, Michel P, Pierard L, Turc G, Barthelet M, Charles-Nelson A, Weimar C, Moulin T, Juliard JM, Chatellier G (2017) Patent foramen ovale closure or anticoagulation vs antiplatelets after stroke. N Engl J Med 377:1011\u20131021. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1705915","journal-title":"N Engl J Med"},{"key":"8766_CR20","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. \n                    https:\/\/doi.org\/10.1136\/bmj.b2535","journal-title":"BMJ"},{"key":"8766_CR21","unstructured":"Higgins JPT, Green S (eds) (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration. \n                    http:\/\/www.handbook.cochrane.org"},{"key":"8766_CR22","unstructured":"Mooney MR (2006) CARDIA STAR trial: a United States randomized clinical trial of the CARDIA STAR patent foramen ovale closure system. \n                    http:\/\/www.mplsheart.com\/pages\/Research.asp?ID=10&SID=28\n                    \n                  . Accessed by the Cochrane Stroke Group"},{"key":"8766_CR23","unstructured":"Hansen CS, Tonder N, Iversen KK (2009) The effect of device closure of patent foramen ovale in elderly patients with cryptogenic stroke\/TCI. \n                    http:\/\/www.ClinicalTrials.gov"},{"key":"8766_CR24","unstructured":"Rosin L, Berger F (2002) PEPSIS: paradoxical embolism prevention study in ischemic stroke. PEPSIS Trial Website. \n                    http:\/\/www.pepsis.stroke-trial.com\n                    \n                  . Accessed by the Cochrane Stroke Group"},{"key":"8766_CR25","unstructured":"Song JK, Lee JY (2012) Device closure versus medical therapy for cryptogenic stroke patients with high-risk patent foramen ovale (DEFENSE-PFO). \n                    http:\/\/www.ClinicalTrials.gov"},{"key":"8766_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.11.027","author":"M Vaduganathan","year":"2017","unstructured":"Vaduganathan M, Qamar A, Gupta A, Bajaj N, Golwala HB, Pandey A, Bhatt DL (2017) Patent foramen ovale closure for secondary prevention of cryptogenic stroke: updated meta-analysis of randomized clinical trials. Am J Med. \n                    https:\/\/doi.org\/10.1016\/j.amjmed.2017.11.027","journal-title":"Am J Med"},{"issue":"4","key":"8766_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ccd.20108","volume":"62","author":"F Alameddine","year":"2004","unstructured":"Alameddine F, Block PC (2004) Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry. Catheter Cardiovasc Interv 62(4):512\u2013516. \n                    https:\/\/doi.org\/10.1002\/ccd.20108","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"8766_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ehj.2003.10.021","volume":"25","author":"M Braun","year":"2004","unstructured":"Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H, Haass M, Schraeder R, Strasser RH (2004) Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 25(5):424\u2013430. \n                    https:\/\/doi.org\/10.1016\/j.ehj.2003.10.021","journal-title":"Eur Heart J"},{"key":"8766_CR29","first-page":"A8807","volume":"21","author":"ED Cillis","year":"2010","unstructured":"Cillis ED, Basile DP, Acquaviva T, Blasi RD, Petruzzellis M, Bortone AS (2010) Abstract 8807: efficacy and effectiveness evaluation of secondary prevention of cryptogenic stroke or TIA in patients with PFO successfully treated by percutaneous approach: six years follow-up. Circulation 21:A8807","journal-title":"Circulation"},{"issue":"4","key":"8766_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/ccd.10674","volume":"60","author":"TE Hong","year":"2003","unstructured":"Hong TE, Thaler D, Brorson J, Heitschmidt M, Hijazi ZM (2003) Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the US multicenter clinical trial. Catheter Cardiovasc Interv 60(4):524\u2013528. \n                    https:\/\/doi.org\/10.1002\/ccd.10674","journal-title":"Catheter Cardiovasc Interv"},{"key":"8766_CR31","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1056\/NEJMp1700218","volume":"377","author":"A Farb","year":"2017","unstructured":"Farb A, Ibrahim NG, Zuckerman BD (2017) Patent foramen ovale after cryptogenic stroke\u2014assessing the evidence for closure. N Engl J Med 377:1006\u20131009. \n                    https:\/\/doi.org\/10.1056\/NEJMp1700218","journal-title":"N Engl J Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-8766-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8766-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8766-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T19:05:40Z","timestamp":1548788740000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-8766-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,30]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["8766"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-8766-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,30]]},"assertion":[{"value":"23 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard statement"}}]}}